India Globalization Capital logo

India Globalization CapitalNYSE American: IGC

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

24 May 2006

Next earnings report:

13 November 2024

Last dividends:

N/A

Next dividends:

N/A
$29.73 M
-62%vs. 3y high
28%vs. sector
-vs. 3y high
-vs. sector
-44%vs. 3y high
75%vs. sector
-88%vs. 3y high
87%vs. sector

Price

regular market | 8 min ago
$0.39-$0.01(-1.73%)

Dividend

No data over the past 3 years
$272.00 K$300.00 K
$272.00 K-$2.38 M

Analysts recommendations

Institutional Ownership

IGC Latest News

IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge
accesswire.com03 October 2024 Sentiment: POSITIVE

POTOMAC, MD / ACCESSWIRE / October 3, 2024 / IGC Pharma, Inc. (NYSE American:IGC) proudly announces that it won 2 awards in the PREPARE Challenge (Pioneering Research for Early Prediction of Alzheimer's and Related Dementias EUREKA Challenge), with its entry of the Mexican Health and Aging Study ("MHAS") database. IGC Pharma, Inc. The PREPARE Challenge is sponsored by the National Institute on Aging ("NIA"), an institute of the National Institutes of Health ("NIH").

Nokia deploys high-performance cross-border DWDM network for IGC
globenewswire.com22 September 2024 Sentiment: POSITIVE

Nokia's Dense Wavelength Division Multiplexing (DWDM) solution was used by IGC to overlay and enhance the existing infrastructure to more effectively manage the growing capacity demand.

IGC Reports Financial Results for Fiscal Year Ended March 31, 2024
businesswire.com24 June 2024 Sentiment: POSITIVE

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Reports Financial Results for Fiscal Year Ended March 31, 2024.

IGC Pharma to Attend BIO International Convention 2024
businesswire.com21 May 2024 Sentiment: POSITIVE

POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Pharma to Attend BIO International Convention 2024.

What type of business is India Globalization Capital?

IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.

What sector is India Globalization Capital in?

India Globalization Capital is in the Healthcare sector

What industry is India Globalization Capital in?

India Globalization Capital is in the Biotechnology industry

What country is India Globalization Capital from?

India Globalization Capital is headquartered in United States

When did India Globalization Capital go public?

India Globalization Capital initial public offering (IPO) was on 24 May 2006

What is India Globalization Capital website?

https://igcpharma.com

Is India Globalization Capital in the S&P 500?

No, India Globalization Capital is not included in the S&P 500 index

Is India Globalization Capital in the NASDAQ 100?

No, India Globalization Capital is not included in the NASDAQ 100 index

Is India Globalization Capital in the Dow Jones?

No, India Globalization Capital is not included in the Dow Jones index

When was India Globalization Capital the previous earnings report?

No data

When does India Globalization Capital earnings report?

The next expected earnings date for India Globalization Capital is 13 November 2024